N-(3-((1H-pyrazol-3-yl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)-5-(pyridin-2-yl)thiophene-2-sulfonamide

InChIKey	`OSRBIQHRPHNLEN-UHFFFAOYSA-N`
Compound Name	N-(3-((1H-pyrazol-3-yl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)-5-(pyridin-2-yl)thiophene-2-sulfonamide
Canonical SMILES	`O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccc(-c2ccccn2)s1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	6.65
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P50406	HTR6	Homo sapiens	Human	PF00001	6.8	Ki	ChEMBL
P10635	CYP2D6	Homo sapiens	Human	PF00067	6.7	IC50	ChEMBL;BindingDB
P35462	DRD3	Homo sapiens	Human	PF00001	6.7	Ki	ChEMBL
P11712	CYP2C9	Homo sapiens	Human	PF00067	6.4	IC50	ChEMBL;BindingDB